— Know what they know.
Not Investment Advice

CBT NYSE

Cabot Corporation
1W: -4.6% 1M: +3.9% 3M: +4.2% YTD: +17.5% 1Y: +5.8% 3Y: +21.3% 5Y: +39.1%
$83.41
+5.07 (+6.47%)
 
Weekly Expected Move ±4.7%
$73 $77 $81 $85 $89
NYSE · Basic Materials · Chemicals - Specialty · Alpha Radar Neutral · Power 53 · $4.3B mcap · 51M float · 0.835% daily turnover · Short 80% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.6 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 14.5%  ·  5Y Avg: 15.8%
Cost Advantage ★
63
Intangibles
50
Switching Cost
35
Network Effect
23
Scale
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CBT shows a Weak competitive edge (45.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 14.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$86
Low
$86
Avg Target
$86
High
Based on 1 analyst since May 5, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 7Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$86.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 UBS $74 $86 +12 +1.5% $84.70
2026-02-04 Mizuho Securities $80 $75 -5 -4.7% $78.73
2026-02-04 Jefferies Laurence Alexander $81 $85 +4 +8.0% $78.73
2026-01-12 UBS Joshua Spector $81 $74 -7 +1.4% $72.96
2026-01-08 UBS $82 $81 -1 +12.7% $71.89
2026-01-08 Jefferies Laurence Alexander $127 $81 -46 +12.8% $71.80
2025-12-18 Mizuho Securities John Roberts $88 $80 -8 +18.5% $67.53
2025-10-03 Mizuho Securities $104 $88 -16 +16.4% $75.60
2025-08-05 UBS Joshua Spector Initiated $82 +2.4% $80.10
2024-09-25 Jefferies Laurence Alexander Initiated $127 +15.2% $110.22
2024-04-18 Deutsche Bank David Begleiter Initiated $95 +3.3% $91.93
2024-03-26 Mizuho Securities John Roberts Initiated $104 +16.2% $89.52

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CBT receives an overall rating of A-. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-06 C A-
2026-05-05 A- C
2026-04-01 B+ A-
2026-02-04 B- B+
2026-02-04 B+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

53 Grade B
Profitability
45
Balance Sheet
66
Earnings Quality
61
Growth
16
Value
70
Momentum
50
Safety
80
Cash Flow
69
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CBT scores highest in Safety (80/100) and lowest in Growth (16/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.41
Safe Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.03
Unlikely Manipulator
Ohlson O-Score
-7.79
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 77.2/100
Trend: Deteriorating
Earnings Quality
75/100
OCF/NI: 2.35x
Accruals: -10.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CBT scores 3.41, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CBT scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CBT's score of -3.03 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CBT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CBT receives an estimated rating of A+ (score: 77.2/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CBT's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
15.22x
PEG
-0.48x
P/S
1.20x
P/B
2.77x
P/FCF
8.56x
P/OCF
5.86x
EV/EBITDA
6.51x
EV/Revenue
1.37x
EV/EBIT
8.40x
EV/FCF
10.65x
Earnings Yield
7.25%
FCF Yield
11.68%
Shareholder Yield
7.05%
Graham Number
$60.40
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 15.2x earnings, CBT trades at a reasonable valuation. An earnings yield of 7.2% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $60.40 per share, 38% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.554
NI / EBT
×
Interest Burden
0.883
EBT / EBIT
×
EBIT Margin
0.163
EBIT / Rev
×
Asset Turnover
0.947
Rev / Assets
×
Equity Multiplier
2.538
Assets / Equity
=
ROE
19.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CBT's ROE of 19.2% is driven by Asset Turnover (0.947), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.55 suggests the company retains less than 60% of pre-tax earnings after taxes.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$46.41
Price/Value
1.62x
Margin of Safety
-62.28%
Premium
62.28%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CBT's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. CBT trades at a 62% premium to its adjusted intrinsic value of $46.41, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 15.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$83.39
Median 1Y
$88.05
5th Pctile
$45.18
95th Pctile
$170.96
Ann. Volatility
38.3%
Analyst Target
$86.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Sean D. Keohane
President and CEO
$1,100,000 $4,224,847 $9,307,883
Jeff Zhu President,
Vice President and President, Carbon and Silica Technologies, and Battery Materials businesses within Performance Chemicals Segment & Asia Pacific Region
$577,472 $714,893 $3,524,533
Erica McLaughlin President,
Vice President, CFO, & Head of Corp Strategy
$625,767 $974,885 $2,776,056
Hobart C. Kalkstein
Former Executive Vice President & President, Reinforcement Materials Segment & Americas Region, & executive responsible for Digital
$605,095 $779,862 $2,578,532
Karen A. Kalita
Senior Vice President and General Counsel
$549,632 $552,412 $1,981,973
Matthew F. Wood
Former Senior Vice President & President, Reinforcement Materials Segment
$371,764 $329,889 $1,305,924

CEO Pay Ratio

147:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,307,883
Avg Employee Cost (SGA/emp): $63,415
Employees: 4,100

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
4,100
-2.4% YoY
Revenue / Employee
$905,610
Rev: $3,713,000,000
Profit / Employee
$80,732
NI: $331,000,000
SGA / Employee
$63,415
Avg labor cost proxy
R&D / Employee
$14,390
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -6.0% 30.5% 12.3% 16.2% 17.6% 22.7% 38.2% 34.7% 33.1% 41.2% 40.8% 43.9% 46.4% 30.1% 33.3% 32.2% 31.6% 22.3% 20.9% 19.2% 19.16%
ROA -1.8% 8.2% 3.3% 4.4% 4.7% 6.1% 10.3% 9.4% 8.9% 12.5% 12.4% 13.3% 14.1% 11.0% 12.2% 11.8% 11.6% 8.8% 8.2% 7.5% 7.55%
ROIC -1.0% 15.7% 13.9% 15.3% 15.7% 18.2% 18.9% 18.3% 17.7% 23.5% 24.0% 25.3% 26.3% 21.8% 22.6% 21.8% 21.4% 16.3% 15.4% 14.5% 14.46%
ROCE 13.5% 21.1% 12.2% 13.5% 15.0% 16.2% 24.0% 22.9% 22.4% 19.5% 19.8% 21.4% 22.2% 21.1% 22.6% 22.4% 22.3% 22.4% 21.5% 20.4% 20.36%
Gross Margin 23.3% 19.7% 20.6% 21.2% 20.5% 19.8% 18.8% 20.3% 23.0% 23.3% 22.8% 25.2% 25.2% 24.0% 24.6% 25.7% 26.4% 24.5% 24.9% 24.0% 24.00%
Operating Margin 14.6% 8.2% 12.0% 13.2% 14.8% 12.9% 11.2% 12.5% 15.5% 14.7% 14.2% 16.9% 16.9% 15.0% 16.2% 17.3% 18.1% 15.2% 15.2% 15.2% 15.15%
Net Margin 9.4% 3.2% -9.2% 9.8% 8.4% 8.5% 5.6% 7.3% 8.5% 24.2% 5.2% 10.7% 10.7% 13.7% 9.7% 10.0% 10.9% 4.8% 8.6% 7.5% 7.52%
EBITDA Margin 19.1% 13.4% -4.2% 17.8% 17.7% 16.4% 14.7% 16.4% 19.6% 19.2% 16.4% 21.0% 21.0% 19.1% 20.8% 22.2% 23.1% 19.5% 20.8% 20.6% 20.58%
FCF Margin 3.3% 1.8% -0.2% -1.7% -2.6% -2.6% -0.3% 3.0% 7.5% 8.9% 9.8% 10.4% 10.1% 11.3% 11.2% 7.4% 9.1% 10.5% 11.1% 12.8% 12.84%
OCF Margin 8.1% 7.5% 5.2% 3.4% 2.3% 2.3% 4.7% 8.3% 13.8% 15.1% 16.5% 16.9% 15.8% 17.3% 17.8% 15.6% 17.0% 17.9% 18.5% 18.8% 18.77%
ROE 3Y Avg snapshot only 28.78%
ROE 5Y Avg snapshot only 27.21%
ROA 3Y Avg snapshot only 10.75%
ROIC 3Y Avg snapshot only 13.36%
ROIC Economic snapshot only 13.46%
Cash ROA snapshot only 17.59%
Cash ROIC snapshot only 26.77%
CROIC snapshot only 18.31%
NOPAT Margin snapshot only 10.14%
Pretax Margin snapshot only 14.38%
R&D / Revenue snapshot only 1.59%
SGA / Revenue snapshot only 7.44%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -57.84 10.44 29.10 27.18 23.41 16.23 10.12 12.84 11.76 8.34 10.14 10.43 9.88 14.82 10.95 10.25 9.38 12.18 11.27 13.79 15.219
P/S Ratio 0.93 0.77 0.81 0.93 0.82 0.79 0.82 0.97 0.88 0.94 1.14 1.27 1.25 1.50 1.23 1.14 1.04 1.09 0.97 1.10 1.204
P/B Ratio 4.27 2.76 3.10 3.82 3.56 3.78 3.97 4.58 4.00 2.94 3.54 3.92 3.92 4.21 3.44 3.12 2.80 2.60 2.26 2.54 2.766
P/FCF 28.64 42.09 -326.54 -55.62 -31.80 -30.56 -237.38 32.36 11.73 10.57 11.62 12.17 12.43 13.31 10.97 15.42 11.45 10.31 8.74 8.56 8.565
P/OCF 11.52 10.15 15.72 27.39 35.48 33.93 17.72 11.64 6.38 6.24 6.90 7.48 7.92 8.67 6.90 7.30 6.13 6.06 5.26 5.86 5.859
EV/EBITDA 8.65 6.00 9.47 10.45 9.33 8.76 6.77 7.80 7.19 7.05 7.98 8.16 7.92 8.94 7.13 6.60 6.04 6.28 5.77 6.51 6.509
EV/Revenue 1.27 1.08 1.11 1.21 1.08 1.09 1.13 1.27 1.20 1.23 1.43 1.56 1.54 1.73 1.46 1.37 1.28 1.34 1.24 1.37 1.367
EV/EBIT 13.12 8.10 15.22 16.13 13.73 11.99 8.42 9.78 9.07 8.92 10.15 10.21 9.84 11.09 8.69 8.08 7.43 7.78 7.26 8.40 8.399
EV/FCF 38.86 59.47 -446.31 -72.20 -41.97 -42.46 -325.38 42.76 16.04 13.77 14.53 14.93 15.24 15.34 13.02 18.60 14.08 12.76 11.13 10.65 10.650
Earnings Yield -1.7% 9.6% 3.4% 3.7% 4.3% 6.2% 9.9% 7.8% 8.5% 12.0% 9.9% 9.6% 10.1% 6.7% 9.1% 9.8% 10.7% 8.2% 8.9% 7.2% 7.25%
FCF Yield 3.5% 2.4% -0.3% -1.8% -3.1% -3.3% -0.4% 3.1% 8.5% 9.5% 8.6% 8.2% 8.0% 7.5% 9.1% 6.5% 8.7% 9.7% 11.4% 11.7% 11.68%
Price/Tangible Book snapshot only 2.888
EV/OCF snapshot only 7.285
EV/Gross Profit snapshot only 5.480
Acquirers Multiple snapshot only 8.576
Shareholder Yield snapshot only 7.05%
Graham Number snapshot only $60.40
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.85 1.24 1.24 1.24 1.24 1.65 1.65 1.65 1.65 1.98 1.98 1.98 1.98 2.08 2.08 2.08 2.08 1.61 1.61 1.61 1.608
Quick Ratio 1.17 0.79 0.79 0.79 0.79 1.05 1.05 1.05 1.05 1.27 1.27 1.27 1.27 1.36 1.36 1.36 1.36 1.08 1.08 1.08 1.082
Debt/Equity 1.74 1.32 1.32 1.32 1.32 1.70 1.70 1.70 1.70 1.08 1.08 1.08 1.08 0.80 0.80 0.80 0.80 0.78 0.78 0.78 0.784
Net Debt/Equity 1.52 1.14 1.14 1.14 1.14 1.47 1.47 1.47 1.47 0.89 0.89 0.89 0.89 0.64 0.64 0.64 0.64 0.62 0.62 0.62 0.617
Debt/Assets 0.43 0.38 0.38 0.38 0.38 0.43 0.43 0.43 0.43 0.38 0.38 0.38 0.38 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.318
Debt/EBITDA 2.60 2.03 2.94 2.78 2.61 2.84 2.12 2.19 2.23 1.98 1.94 1.83 1.77 1.47 1.40 1.41 1.41 1.53 1.57 1.62 1.618
Net Debt/EBITDA 2.27 1.75 2.54 2.40 2.26 2.45 1.83 1.90 1.93 1.64 1.60 1.51 1.46 1.18 1.12 1.13 1.13 1.20 1.24 1.27 1.274
Interest Coverage 6.22 9.29 5.39 6.19 6.48 7.02 8.79 7.12 6.22 6.02 6.12 6.92 7.63 7.90 8.93 8.84 8.80 8.43 8.09 7.66 7.658
Equity Multiplier 4.02 3.49 3.49 3.49 3.49 3.93 3.93 3.93 3.93 2.85 2.85 2.85 2.85 2.62 2.62 2.62 2.62 2.46 2.46 2.46 2.461
Cash Ratio snapshot only 0.270
Debt Service Coverage snapshot only 9.882
Cash to Debt snapshot only 0.212
FCF to Debt snapshot only 0.378
Defensive Interval snapshot only 1053.1 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 1.09 1.12 1.19 1.28 1.35 1.27 1.26 1.25 1.19 1.10 1.10 1.10 1.11 1.09 1.09 1.06 1.04 0.98 0.96 0.95 0.947
Inventory Turnover 5.83 5.92 6.41 6.93 7.41 5.79 5.81 5.75 5.47 4.95 4.88 4.78 4.80 5.31 5.28 5.16 5.02 5.25 5.10 5.08 5.081
Receivables Turnover 6.68 6.41 6.83 7.30 7.74 5.84 5.83 5.75 5.51 5.14 5.13 5.10 5.17 5.59 5.59 5.47 5.34 5.29 5.14 5.09 5.093
Payables Turnover 6.82 6.56 7.10 7.68 8.21 6.78 6.81 6.74 6.40 6.37 6.28 6.15 6.18 5.42 5.39 5.27 5.13 4.89 4.74 4.73 4.728
DSO 55 57 53 50 47 63 63 63 66 71 71 72 71 65 65 67 68 69 71 72 71.7 days
DIO 63 62 57 53 49 63 63 63 67 74 75 76 76 69 69 71 73 69 72 72 71.8 days
DPO 54 56 51 48 44 54 54 54 57 57 58 59 59 67 68 69 71 75 77 77 77.2 days
Cash Conversion Cycle 64 63 59 55 52 72 72 73 76 87 88 89 88 67 67 68 70 64 66 66 66.3 days
Fixed Asset Turnover snapshot only 2.089
Operating Cycle snapshot only 143.5 days
Cash Velocity snapshot only 13.857
Capital Intensity snapshot only 1.067
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 13.7% 30.4% 37.9% 40.4% 30.0% 26.8% 18.9% 9.7% -0.9% -9.0% -9.1% -8.3% -3.0% 1.5% 1.6% 0.0% -3.5% -7.0% -9.6% -8.5% -8.52%
Net Income -1.8% 2.1% 1.5% 1.9% 3.8% -16.4% 2.5% 1.4% 1.1% 1.1% 25.3% 48.4% 64.6% -9.0% 1.6% -8.8% -15.3% -18.3% -30.6% -34.2% -34.18%
EPS -1.8% 2.0% 1.5% 1.9% 3.8% -16.3% 2.5% 1.4% 1.1% 1.2% 27.3% 51.4% 67.0% -7.5% 3.1% -6.7% -12.3% -15.5% -27.8% -31.4% -31.41%
FCF -57.4% -65.0% -1.1% -1.4% -2.0% -2.8% -66.7% 3.0% 3.9% 4.2% 26.7% 2.2% 30.4% 28.5% 16.1% -29.2% -12.8% -13.3% -10.3% 59.4% 59.38%
EBITDA 41.2% 2.5% 88.4% 36.5% 3.0% -12.5% 70.0% 55.0% 43.2% 27.5% -2.8% 7.0% 12.4% 12.8% 16.4% 8.9% 5.6% 2.7% -5.3% -7.4% -7.40%
Op. Income 86.7% 20.6% 4.9% 1.6% 62.6% 26.2% 25.0% 17.5% 5.2% -7.7% -1.4% 9.1% 17.4% 19.1% 16.5% 6.5% 1.9% -1.4% -8.3% -10.8% -10.80%
OCF Growth snapshot only 10.36%
Asset Growth snapshot only 2.11%
Equity Growth snapshot only 8.77%
Debt Growth snapshot only 6.58%
Shares Change snapshot only -4.04%
Dividend Growth snapshot only 2.11%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 0.5% 1.7% 2.8% 4.8% 7.0% 9.0% 10.0% 11.1% 13.6% 14.6% 14.2% 12.2% 7.7% 5.4% 3.2% 0.2% -2.5% -4.9% -5.8% -5.7% -5.67%
Revenue 5Y 5.1% 7.2% 8.5% 8.9% 9.5% 9.7% 8.8% 7.5% 5.5% 3.9% 3.3% 3.0% 3.3% 3.6% 4.2% 4.7% 6.5% 7.3% 6.5% 5.3% 5.27%
EPS 3Y 11.1% -20.4% -12.1% 10.5% 40.0% 44.8% 65.7% 18.6% 66.1% 50.6% 46.1% 19.0% -1.8% -1.0% -1.04%
EPS 5Y 13.2% -11.9% -9.1% -6.7% -0.9% 42.7% 43.5% 13.0% 19.3% 21.9% 29.2% 33.8% 46.1%
Net Income 3Y 9.0% -21.4% -12.9% 10.0% 39.7% 45.0% 65.7% 17.4% 64.3% 48.2% 43.4% 16.6% -4.0% -3.8% -3.79%
Net Income 5Y 10.9% -13.6% -10.8% -8.5% -2.8% 40.2% 41.4% 11.6% 18.2% 20.9% 28.3% 32.8% 44.7%
EBITDA 3Y 15.2% 29.1% 17.4% -2.2% 1.7% 5.4% 17.6% 19.6% 27.7% 56.8% 46.1% 31.3% 18.4% 8.0% 24.4% 21.8% 19.4% 13.9% 2.3% 2.6% 2.57%
EBITDA 5Y 0.5% 5.9% -2.5% -2.1% -0.7% 1.3% 6.5% 20.0% 17.7% 19.1% 21.8% 9.2% 11.1% 11.0% 13.0% 14.8% 19.8% 34.9% 28.0% 17.9% 17.95%
Gross Profit 3Y 1.0% 0.8% 1.5% 2.8% 5.1% 9.0% 9.6% 10.0% 16.0% 18.8% 16.6% 14.6% 8.0% 6.7% 7.0% 5.7% 4.4% 2.0% 1.8% 1.8% 1.78%
Gross Profit 5Y 6.6% 6.7% 4.8% 4.7% 5.2% 6.3% 5.2% 4.0% 2.6% 1.4% 2.6% 4.0% 5.6% 7.2% 8.4% 8.9% 12.4% 13.5% 10.7% 7.8% 7.79%
Op. Income 3Y 34.6% 42.8% 48.2% 8.1% 13.8% 23.3% 24.6% 31.3% 47.3% 1.9% 94.2% 49.4% 26.1% 11.5% 12.8% 10.9% 7.9% 2.7% 1.7% 1.2% 1.20%
Op. Income 5Y 5.9% 12.7% 7.2% 7.0% 8.7% 11.3% 10.2% 40.6% 33.1% 27.7% 32.0% 10.2% 12.7% 15.5% 17.3% 21.3% 30.7% 96.9% 50.9% 25.9% 25.93%
FCF 3Y 12.7% -4.0% -13.0% 8.1% 25.6% 42.9% 30.3% 57.1% 93.8% 53.5% 53.46%
FCF 5Y -23.3% -25.7% -4.4% 33.6% 38.1% 50.9% 30.6% 26.9% 10.9% 8.3% 7.5% 17.2% 24.9% 20.1% 20.06%
OCF 3Y -5.1% -5.7% -5.6% -21.8% -33.9% -34.8% -26.4% -7.0% 5.9% 16.4% 30.3% 25.6% 34.7% 39.1% 56.1% 66.4% 89.8% 88.1% 49.2% 23.9% 23.87%
OCF 5Y -12.7% -7.8% -14.3% -11.9% -19.1% -21.7% -6.6% -0.9% 13.4% 14.2% 23.9% 19.1% 13.7% 13.9% 7.1% 6.7% 6.6% 12.0% 17.9% 15.0% 14.97%
Assets 3Y -5.7% 0.6% 0.6% 0.6% 0.6% 5.5% 5.5% 5.5% 5.5% 9.0% 9.0% 9.0% 9.0% 4.2% 4.2% 4.2% 4.2% 2.7% 2.7% 2.7% 2.67%
Assets 5Y -2.0% 0.9% 0.9% 0.9% 0.9% 1.3% 1.3% 1.3% 1.3% 2.1% 2.1% 2.1% 2.1% 4.5% 4.5% 4.5% 4.5% 6.5% 6.5% 6.5% 6.53%
Equity 3Y -22.4% -6.4% -6.4% -6.4% -6.4% -3.5% -3.5% -3.5% -3.5% 22.3% 22.3% 22.3% 22.3% 14.6% 14.6% 14.6% 14.6% 20.0% 20.0% 20.0% 19.96%
Book Value 3Y -20.1% -3.8% -4.6% -5.2% -5.5% -3.0% -3.3% -3.6% -3.5% 22.6% 22.9% 23.0% 23.2% 15.8% 15.8% 16.5% 16.7% 22.4% 22.8% 23.4% 23.38%
Dividend 3Y 3.0% 2.7% 2.3% 2.1% 2.2% 2.1% 1.4% 0.7% 1.2% 1.8% 2.4% 3.3% 3.1% 2.9% 3.3% 3.1% 2.9% 3.2% 2.7% 3.6% 3.57%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.34 0.31 0.36 0.44 0.57 0.54 0.56 0.59 0.59 0.44 0.39 0.40 0.53 0.51 0.57 0.51 0.46 0.35 0.29 0.25 0.251
Earnings Stability 0.15 0.03 0.24 0.03 0.01 0.02 0.11 0.22 0.36 0.54 0.42 0.23 0.42 0.51 0.63 0.71 0.81 0.59 0.62 0.56 0.564
Margin Stability 0.91 0.90 0.90 0.91 0.89 0.90 0.93 0.93 0.90 0.91 0.95 0.94 0.92 0.92 0.91 0.90 0.88 0.88 0.90 0.91 0.908
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.90 0.81 0.50 0.96 0.99 0.96 0.94 0.93 0.88 0.86 0.863
Earnings Smoothness 0.82 0.00 0.17 0.28 0.28 0.78 0.61 0.51 0.91 0.98 0.91 0.83 0.80 0.64 0.59 0.588
ROE Trend -0.20 0.36 0.20 0.19 0.16 0.27 0.50 0.39 0.30 0.10 0.10 0.13 0.15 -0.01 -0.06 -0.06 -0.07 -0.10 -0.13 -0.16 -0.156
Gross Margin Trend 0.04 0.04 0.02 -0.00 -0.01 -0.01 -0.01 -0.02 -0.02 -0.01 0.01 0.03 0.04 0.03 0.04 0.03 0.03 0.02 0.02 0.01 0.007
FCF Margin Trend -0.03 -0.04 -0.07 -0.08 -0.09 -0.07 -0.03 0.00 0.07 0.09 0.10 0.10 0.08 0.08 0.06 0.01 0.00 0.00 0.01 0.04 0.039
Sustainable Growth Rate 20.8% 2.4% 6.2% 7.4% 13.6% 29.1% 25.6% 23.7% 33.0% 32.6% 35.5% 37.9% 23.2% 26.3% 25.1% 24.5% 15.8% 14.5% 12.6% 12.64%
Internal Growth Rate 5.9% 0.7% 1.7% 2.0% 3.8% 8.5% 7.4% 6.9% 11.1% 11.0% 12.1% 13.0% 9.3% 10.6% 10.1% 9.9% 6.6% 6.0% 5.2% 5.24%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income -5.02 1.03 1.85 0.99 0.66 0.48 0.57 1.10 1.84 1.34 1.47 1.39 1.25 1.71 1.59 1.40 1.53 2.01 2.14 2.35 2.354
FCF/OCF 0.40 0.24 -0.05 -0.49 -1.12 -1.11 -0.07 0.36 0.54 0.59 0.59 0.61 0.64 0.65 0.63 0.47 0.54 0.59 0.60 0.68 0.684
FCF/Net Income snapshot only 1.611
OCF/EBITDA snapshot only 0.893
CapEx/Revenue 4.8% 5.7% 5.4% 5.1% 4.9% 4.9% 5.0% 5.3% 6.3% 6.2% 6.7% 6.5% 5.7% 6.0% 6.6% 8.2% 7.9% 7.4% 7.4% 5.9% 5.93%
CapEx/Depreciation snapshot only 1.254
Accruals Ratio -0.11 -0.00 -0.03 0.00 0.02 0.03 0.04 -0.01 -0.08 -0.04 -0.06 -0.05 -0.03 -0.08 -0.07 -0.05 -0.06 -0.09 -0.09 -0.10 -0.102
Sloan Accruals snapshot only -0.111
Cash Flow Adequacy snapshot only 2.172
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 2.7% 3.1% 2.8% 2.3% 2.5% 2.5% 2.4% 2.0% 2.4% 2.4% 2.0% 1.8% 1.9% 1.5% 1.9% 2.1% 2.4% 2.4% 2.7% 2.5% 2.16%
Dividend/Share $1.40 $1.41 $1.43 $1.44 $1.46 $1.48 $1.48 $1.48 $1.52 $1.57 $1.59 $1.63 $1.65 $1.68 $1.73 $1.75 $1.77 $1.80 $1.81 $1.86 $1.80
Payout Ratio 32.0% 80.2% 61.7% 57.6% 40.2% 23.9% 26.2% 28.2% 19.8% 20.2% 19.2% 18.3% 23.0% 21.2% 21.9% 22.4% 29.0% 30.9% 34.0% 34.04%
FCF Payout Ratio 77.7% 1.3% 66.1% 28.1% 25.1% 23.1% 22.4% 23.1% 20.6% 21.3% 33.0% 27.3% 24.6% 23.9% 21.1% 21.13%
Total Payout Ratio 33.2% 1.0% 88.0% 91.7% 65.6% 38.4% 42.5% 45.6% 41.8% 46.0% 44.8% 49.4% 65.4% 61.6% 69.1% 68.2% 79.8% 88.1% 97.2% 97.19%
Div. Increase Streak 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Chowder Number 0.03 0.03 0.04 0.05 0.06 0.07 0.06 0.04 0.06 0.07 0.08 0.10 0.09 0.07 0.09 0.07 0.06 0.06 0.04 0.05 0.046
Buyback Yield 0.1% 0.1% 0.7% 1.0% 1.5% 1.6% 1.4% 1.3% 1.5% 2.6% 2.5% 2.5% 3.1% 2.9% 3.7% 4.6% 4.9% 4.2% 5.1% 4.6% 4.58%
Net Buyback Yield -0.1% -0.1% 0.5% 0.8% 1.2% 1.4% 1.2% 1.1% 1.4% 2.5% 2.4% 2.2% 2.8% 2.5% 3.4% 4.4% 4.7% 4.0% 4.9% 4.4% 4.43%
Total Shareholder Return 2.6% 3.0% 3.3% 3.0% 3.7% 3.9% 3.5% 3.1% 3.8% 4.9% 4.4% 4.0% 4.7% 4.1% 5.3% 6.5% 7.1% 6.3% 7.6% 6.9% 6.89%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) -0.20 0.61 0.46 0.53 0.52 0.61 0.67 0.66 0.66 0.98 0.95 0.93 0.93 0.74 0.75 0.73 0.72 0.58 0.57 0.55 0.554
Interest Burden (EBT/EBIT) 0.85 0.90 0.83 0.86 0.86 0.88 0.90 0.87 0.85 0.84 0.84 0.86 0.88 0.88 0.90 0.90 0.90 0.89 0.89 0.88 0.883
EBIT Margin 0.10 0.13 0.07 0.07 0.08 0.09 0.13 0.13 0.13 0.14 0.14 0.15 0.16 0.16 0.17 0.17 0.17 0.17 0.17 0.16 0.163
Asset Turnover 1.09 1.12 1.19 1.28 1.35 1.27 1.26 1.25 1.19 1.10 1.10 1.10 1.11 1.09 1.09 1.06 1.04 0.98 0.96 0.95 0.947
Equity Multiplier 3.43 3.72 3.72 3.72 3.72 3.70 3.70 3.70 3.70 3.30 3.30 3.30 3.30 2.73 2.73 2.73 2.73 2.54 2.54 2.54 2.538
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.89 $4.39 $1.78 $2.33 $2.54 $3.68 $6.21 $5.63 $5.40 $7.93 $7.90 $8.53 $9.01 $7.34 $8.15 $7.96 $7.90 $6.20 $5.88 $5.46 $5.46
Book Value/Share $12.12 $16.64 $16.67 $16.58 $16.67 $15.81 $15.84 $15.81 $15.89 $22.53 $22.65 $22.69 $22.69 $25.82 $25.91 $26.19 $26.49 $29.03 $29.30 $29.69 $32.44
Tangible Book/Share $7.96 $12.43 $12.45 $12.38 $12.45 $12.43 $12.45 $12.43 $12.50 $19.07 $19.18 $19.21 $19.21 $22.45 $22.53 $22.78 $23.03 $25.49 $25.73 $26.07 $26.07
Revenue/Share $55.51 $59.91 $63.93 $67.97 $72.41 $76.07 $76.16 $74.98 $72.18 $70.07 $70.32 $70.14 $71.01 $72.30 $72.51 $71.84 $70.91 $69.53 $68.19 $68.49 $68.75
FCF/Share $1.81 $1.09 $-0.16 $-1.14 $-1.87 $-1.95 $-0.26 $2.24 $5.42 $6.26 $6.90 $7.31 $7.16 $8.17 $8.13 $5.29 $6.47 $7.32 $7.58 $8.79 $8.83
OCF/Share $4.49 $4.52 $3.29 $2.31 $1.67 $1.76 $3.54 $6.21 $9.95 $10.61 $11.61 $11.89 $11.24 $12.54 $12.93 $11.18 $12.08 $12.45 $12.61 $12.85 $12.90
Cash/Share $2.65 $2.95 $2.96 $2.94 $2.96 $3.63 $3.63 $3.63 $3.65 $4.24 $4.27 $4.27 $4.27 $4.04 $4.05 $4.10 $4.14 $4.83 $4.88 $4.94 $4.85
EBITDA/Share $8.12 $10.81 $7.46 $7.86 $8.40 $9.47 $12.72 $12.25 $12.09 $12.23 $12.56 $13.38 $13.79 $14.02 $14.84 $14.91 $15.07 $14.89 $14.61 $14.39 $14.39
Debt/Share $21.12 $21.90 $21.94 $21.82 $21.94 $26.87 $26.91 $26.87 $27.01 $24.24 $24.37 $24.42 $24.42 $20.65 $20.73 $20.96 $21.19 $22.75 $22.97 $23.28 $23.28
Net Debt/Share $18.47 $18.95 $18.98 $18.88 $18.98 $23.24 $23.28 $23.24 $23.36 $20.00 $20.11 $20.14 $20.14 $16.61 $16.67 $16.86 $17.04 $17.92 $18.09 $18.33 $18.33
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 3.415
Altman Z-Prime snapshot only 5.550
Piotroski F-Score 4 6 6 5 6 7 7 8 8 8 8 8 8 7 7 7 7 6 6 5 5
Beneish M-Score -2.95 -2.02 -2.01 -1.90 -1.83 -2.07 -1.99 -2.26 -2.64 -2.84 -2.90 -2.87 -2.74 -2.79 -2.78 -2.63 -2.70 -3.00 -3.05 -3.03 -3.031
Ohlson O-Score snapshot only -7.787
ROIC (Greenblatt) snapshot only 25.38%
Net-Net WC snapshot only $-10.94
EVA snapshot only $111926459.14
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A+
Credit Score 61.29 53.29 49.65 54.17 53.77 60.36 62.15 65.27 66.60 70.27 73.81 73.91 76.96 82.49 80.18 78.20 80.95 79.58 77.96 77.15 77.152
Credit Grade snapshot only 5
Credit Trend snapshot only -1.047
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 66
Sector Credit Rank snapshot only 72

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms